Pharmacogenomics: Convergence of Pharmacology & Genomics

Personalized medicine can be used to learn about a person's genetic makeup and to unravel the biology of their tumor. Using this information, doctors hope to identify prevention, screening, and treatment strategies that may be more effective and cause fewer side effects than would be expected with standard treatments. By performing more genetic tests and analysis, doctors may customize treatment to each patient's needs. Creating a personalized cancer screening and treatment plan includes: Determining the chances that a person will develop cancer and selecting screening strategies to lower the risk, Matching patients with treatments that are more likely to be effective and cause fewer side effects, Predicting the risk of recurrence (return of cancer)

  • Genotyping & genome sequencing
  • Predictive computational phenotyping
  • Drug metabolizing enzymes
  • New era of Proteomics
  • Protein microarrays for personalized medicine

Related Conference of Pharmacogenomics: Convergence of Pharmacology & Genomics

June 21-22, 2017

3rd International Conference on Cytopathology & Histopathology

Philadelphia, Pennsylvania, USA
June 26-27, 2017

8th World Congress on Molecular Pathology

San Diego,California,USA
August 02-03, 2017

13th European Pathology Congress

Milan, Italy
August 23-24, 2017

4th World Congress on Breast Pathology and Cancer Diagnosis

Toronto, Canada [Holiday Inn Toronto International Airport]
Sep 11-12, 2017

World Annual Pathologists Congress

Los Angeles, USA
November 13-14, 2017

14th Asia Pacific Pathology Congress

Osaka, Japan
November 15-16, 2017

2nd International Conference on Digital Pathology

San Antonio, USA

Pharmacogenomics: Convergence of Pharmacology & Genomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in